Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma

被引：0
|
作者：
Ryosuke Hirohata
Yoichi Hamai
Jun Hihara
Manabu Emi
Tomoaki Kurokawa
Toru Yoshikawa
Manato Ohsawa
Nao Kitasaki
Morihito Okada
机构：
[1] Hiroshima University,Department of Surgical Oncology
来源：
World Journal of Surgery | 2022年 / 46卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1934 / 1943
页数：9
相关论文
共 50 条
  • [21] Comparison of neoadjuvant chemotherapy or chemoradiotherapy plus immunotherapy for locally resectable esophageal squamous cell carcinoma
    Yang, Guozhen
    Yue, Haodong
    Zhang, Xiaomin
    Zeng, Chufeng
    Tan, Linyu
    Zhang, Xu
    [J]. FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [22] Surgery is crucial for advanced esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
    Chen, Haiquan
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (06): : 2722 - 2723
  • [23] Comparison of Aggressive Planned Salvage Surgery Versus Neoadjuvant Chemoradiotherapy Plus Surgery for Borderline Resectable T4 Squamous Cell Carcinoma
    Osamu Shiraishi
    Takushi Yasuda
    Hiroaki Kato
    Kota Momose
    Yoko Hiraki
    Atsushi Yasuda
    Masayuki Shinkai
    Yutaka Kimura
    Motohiro Imano
    [J]. Annals of Surgical Oncology, 2021, 28 : 6366 - 6375
  • [24] Comparison of Aggressive Planned Salvage Surgery Versus Neoadjuvant Chemoradiotherapy Plus Surgery for Borderline Resectable T4 Squamous Cell Carcinoma
    Shiraishi, Osamu
    Yasuda, Takushi
    Kato, Hiroaki
    Momose, Kota
    Hiraki, Yoko
    Yasuda, Atsushi
    Shinkai, Masayuki
    Kimura, Yutaka
    Imano, Motohiro
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (11) : 6366 - 6375
  • [25] Neoadjuvant chemoradiotherapy followed by surgery is associated with better survival outcomes in patients with locally advanced esophageal squamous cell carcinoma
    Yoshida, Naoya
    Baba, Hideo
    [J]. JOURNAL OF THORACIC DISEASE, 2018, 10 : S3067 - S3068
  • [26] A retrospective analysis of neoadjuvant chemotherapy followed by surgery or definitive chemoradiotherapy in patients with advanced esophageal squamous cell carcinoma.
    Nakatsumi, Hiroshi
    Komatsu, Yoshito
    Nakano, Shintaro
    Sawada, Kentaro
    Muranaka, Tetsuhito
    Kawamoto, Yasuyuki
    Yuki, Satoshi
    Uchinami, Yusuke
    Taguchi, Hiroshi
    Shirato, Hiroki
    Ebihara, Yuma
    Shichinohe, Toshiaki
    Hirano, Satoshi
    Sakamoto, Naoya
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [27] Failure of neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma
    Okamura, A.
    Watanabe, M.
    Mine, S.
    Kurogochi, T.
    Yamashita, K.
    Hayami, M.
    Imamura, Y.
    Ogura, M.
    Ichimura, T.
    Takahari, D.
    Chin, K.
    [J]. DISEASES OF THE ESOPHAGUS, 2017, 30 (09): : 1 - 8
  • [28] Neoadjuvant chemoradiotherapy to convert borderline-resectable, locally-advanced esophageal carcinoma to resectable disease.
    Horne, Zachary D.
    Sun, Weijing
    Gibson, Michael K.
    Pennathur, Arjun
    Luketich, James D.
    Greenberger, Joel S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] COMPARISON OF NEOADJUVANT CHEMORADIOTHERAPY FOR RESECTABLE AND BORDERLINE RESECTABLE PERIAMPULLARY CARCINOMA WITH UPFRONT SURGERY: A PROSPECTIVE RANDOMISED STUDY
    Singh, Abhinav
    Gupta, Rajesh
    Rana, Surinder S.
    Kang, Mandeep
    Sharma, Vishal
    Singh, Harjeet
    Kapoor, Rakesh
    [J]. GASTROINTESTINAL ENDOSCOPY, 2018, 87 (06) : AB575 - AB575
  • [30] Neoadjuvant chemoradiotherapy followed by esophagectomy for initially resectable squamous cell carcinoma of the esophagus with multiple lymph node metastasis
    Nabeya, Y
    Ochiai, T
    Matsubara, H
    Okazumi, S
    Shiratori, T
    Shuto, K
    Aoki, T
    Miyazaki, S
    Gunji, Y
    Uno, T
    Ito, H
    Shimada, H
    [J]. DISEASES OF THE ESOPHAGUS, 2005, 18 (06) : 388 - 397
12345